A 55-Year-Old Man with Attention-Deficit/Hyperactivity Disorder
JAMA 280:1086-1092, Biederman,J., 1998
A Simplified Six-Item Checklist for Screening for Fragile X Syndrome in the Pediatric Population
J Pediatr 129:611-614, Giangreco,C.A.,et al, 1996
Adderall and Other Drugs for Attention-Deficit/Hyperactivity Disorder
The Medical Letter, 36:109-1101994., , 1994
Lecanemab for Alzheimer Disease, Is It Worth It?
Neurol 102:e209265, Nelson,S.E. & Lopez,O.L., 2024
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012
Should TIA Patients Be Hospitalized or Referred to a Same-Day Clinic?
Neurol 77-2082-2088, Joshi, J.K.,et al, 2011
Effect of Urgent Treatment of Transient Ischaemic Attack and Minor Stroke on Early Recurrent Stroke (EXPRESS Study): A Prospective Population-Baed Sequential Comparison
Lancet 370:1432-1442,1398, Rothwell,P.M., et al, 2007
Patients With Transient Ischemic Attack Do Not Need to Be Admitted to Hospital for Urgent Evaluation and Treatment: Against.
Stroke 37:1139-1140,1140, Lindley,R.I., 2006
Patients With Transient Ischemic Attack or Minor Stroke Should Be Admitted to Hospital: For
Stroke 37:1137-1138,1140, Hill,M.D. &Gladstone,D.J., 2006
Is Hospitalization After TIA Cost-Effective on the Basis of Treatment With tPA?
Neurol 65:1799-1801, Nguyen-Huynh,M.N. &Johnson,S.C., 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
A Cohort Study of Early Neurological Consultation by Telemedicince on the Care of Neurological Inpatients
JNNP 75:1031-1035, Craig,J.,et al, 2004
Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004
Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004
Intravenous Immunoglobulin in Neurological Disease: A specialist Review
JNNP 72:440-448, Wiles,C.M.,et al, 2002
Inpatient Costs, Length of Stay, and Mortality for Cerebrovascular Events in Community Hospitals
Neurol 57:305-314, Reed,S.D.,et al, 2001
Randomised Controlled Trial of Telemedicine for New Neurological Outpatient Referrals
JNNP 71:63-66, Chua,R.,et al, 2001
Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999
Transeophageal Echocardiography for the Evaluation and Management of Patients with Cerebral Ischemia
Clin Cardiol 22:391-396, Rahmatullah,A.F.,et al, 1999
Does the Neurologist Add Value to the Carotid Endarterectomy Patient
Neurol 50:610-613, Chaturvedi,S.&Hachinski,V., 1998
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
A 45-Year-Old Man with Low Back Pain and a Numb Left Foot
JAMA 280:730-736, Weinstein,J.N., 1998
Minimal Head Trauma in Children Revisited:Is Routine Hospitalization Required
Pediatrics 101:575-577, Roddy,S.P.,et al, 1998
The Antiplatelet Effects of Ticlopidine and Clopidogrel
Ann Int Med 129:394-405, Sharis,P.J.,et al, 1998
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter 39:53-54, , 1997
Cognitive Function and The costs of Alzheimer Disease
Arch Neurol 54:687-683, Ernst,R.L.,et al, 1997
Intravenous Immune Globulin Therapy for Neurologic Diseases
Ann Int Med 126:721-730, Dalakas,M.C., 1997
The Impact of Neurologic Disease on Hospitalizations Related to HIV Infection in Maryland, 1991-1992
Arch Neurol 54:846-852, DalPan,G.J.,et al, 1997
Diagnosing Syncope
Ann Int Med 126:989-996, Linzer,M.,et al, 1997
Acute Stroke:Prognosis & Prediction of Effect of Med Treat Outcome & Health Care Util, Copenhagen Study
Neurol 49:1335-1342, Jorgensen,H.S.,et al, 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Imaging the Brain in Dementia:Expensive and Futile
AJNR 18:1847-1850, George,A.E.,et al, 1997
Proving the Worth of Neurologists?
Neurol 46:276-277, Hillen,M.E.&Sage,J.I., 1996
Inpatient Costs of Specific Cerebrovascular Events at Five Academic Medical Centers
Neurol 46:854-860, 6021996., Holloway,R.G.,et al, 1996
Utilization of Acute Care Services in the Year Before and After First Stroke:A Population-Based Study
Neurol 46:861-869, 6021996., Leibson,C.L.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Problems with Myofascial Pain Syndrome and Fibromyalgia Syndrome
Neurol 46:593-597, Bohr,T., 1996
Routine Transesophageal Echocardiograhy for Cerebral Ischemia
Arch Int Med 156:1719-1723, Warner,M.F.&Kingson,I.M., 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
Diagnosis and Evaluation of Dementia
Neurol 45:211-218, Corey-Bloom,J.,et al, 1995
The Impact of New Pharmaceutical Agents on the Cost of Neurologic Care
Neurol 45:569-572, Gunderson,C.H., 1995
Outcomes of Elderly Stroke Patients:Day Hospital Versus Convential Medical Management
Stroke 26:1616-1619, Hui,E.,et al, 1995
Imaging of Carotid Artery Stenosis:Clinical Efficacy and Cost-effectiveness
AJNR 16:1875-1883, Vanninen,R.,et al, 1995
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Carotid Endarterectomy without Arteriography:The Preeminent Role of the Vascular Laboratory
Ann Vasc Surg 8:221-224, Horn,M.,et al, 1994